KOB 419m
Zepbound tops Wegovy for weight loss in Eli Lilly study
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo ...
Best Life on MSN41m
Ozempic Isn't the No. 1 Treatment for Weight Loss, New Study Finds
If you’ve been debating starting a weight-loss treatment like tirzepatide or semaglutide, you’re going to want to listen ...
These Stocks Are Moving the Most Today: Marvell, Salesforce, Pure Storage, Chewy, GM, Roku, Foot Locker, Couchbase, and More
Stocks were rising Wednesday and tech shares led the charge higher following better-than-expected earnings from Salesforce ...
In new trial, Zepbound bests Wegovy for weight loss
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...